| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/19/2006 | CN1761450A Skin preparation for external use characterized by containing sugar derivative of a,a-trehalose |
| 04/19/2006 | CN1252279C Biodegradable articles obtained from enzymatically synthesized amylose |
| 04/19/2006 | CN1252235C Improved granular material formula |
| 04/19/2006 | CN1252154C Pullulan film compositions |
| 04/19/2006 | CN1252106C (Methyl) hydroxyalkyl acrylate (co) polymer, preparing process and its use |
| 04/19/2006 | CN1251763C Aqueous air foam |
| 04/19/2006 | CN1251707C Application of Engally nut oil in the preparation of medicine for treating arthritis |
| 04/19/2006 | CN1251672C Volume-expansion protection agent and application in treating blood-loss shock |
| 04/19/2006 | CN1251670C Consumable container |
| 04/19/2006 | CN1251668C Ground substance and plaster of Chinese traditional medicine as well as its preparing method |
| 04/18/2006 | USRE39069 Capable of delivering a first active agent in an outer lamina to one environment of use and a second active agent in the core to another environment of use; An erodible polymer coat between internal semipermeable membrane and a second active agent containing vinyl acetate-vinylpyrrolidone copolymer |
| 04/18/2006 | US7030278 Polyethylene(Glycol) derivatives with proximal reactive groups |
| 04/18/2006 | US7030218 Extending ligation technique to peptides, polypeptides, other polymers and other molecules via an amide bond; used in the synthesis of optionally polymer-modified, synthetic bioactive proteins, and of pharmaceutical compositions |
| 04/18/2006 | US7030203 Water-in-oil emulsions with ethylene oxide groups, compositions, and methods |
| 04/18/2006 | US7030162 Storage stabilized dosage |
| 04/18/2006 | US7030155 Mixture of tocopherol and solvent; stabilization with surfactant |
| 04/18/2006 | US7030151 Micronized amorphous form for better bioavailability; hypercholesterolemia, hyperlipidemia |
| 04/18/2006 | US7030149 Combination of brimonidine timolol for topical ophthalmic use |
| 04/18/2006 | US7030106 Ezetimibe formulation with lactose, croscarmellose sodium, povidone, sodium lauryl sulfate, magnesium stearate and microcrystalline cellulose |
| 04/18/2006 | US7030104 Topical oestroprogestational compositions with a systemic effect |
| 04/18/2006 | US7030094 Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and QS-21 |
| 04/18/2006 | US7030093 Antibiotic coating for porous bodies and method for its production as well as its use |
| 04/18/2006 | US7030086 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 04/18/2006 | US7030084 Drug-oligomer conjugates with polyethylene glycol components |
| 04/18/2006 | US7030082 Administering mixtures of calcitonin conjugated to poplyethylene glycol, bile acids and carriers, for prophylaxis of bone disorders |
| 04/18/2006 | US7029918 For reference standards in immunoassays; drug screening |
| 04/18/2006 | US7029895 Comprises nucleotide sequences coding cardiolipin for diagnosis and treatment of lung, heart and respiratory disorders |
| 04/18/2006 | US7029862 Method for identifying ligands, inhibitors or promoters of CXC chemokine receptor 3 |
| 04/18/2006 | US7029699 Mixture containing carbohydrate and binder |
| 04/18/2006 | US7029698 Solubility characteristics for encapsulation; capsular dosage forms |
| 04/18/2006 | US7029694 Compositions and methods for transdermal oxybutynin therapy |
| 04/18/2006 | US7029692 content of monoterpene ketone in the nicotine-containing layer is 0.1 to 5.0%-wt of the weight; masks the unpleasant smell of nicotine |
| 04/18/2006 | US7029691 Conjugated linoleic acid compositions |
| 04/18/2006 | US7029688 Methods and compositions to prevent formation of adhesions in biological tissues |
| 04/18/2006 | US7029678 Vaccines |
| 04/18/2006 | US7029663 substantially anhydrous, using hydrocarbon gel and/or petrolatum as a base; increased storage stability |
| 04/18/2006 | US7029661 blend of an ethyl acrylate/methyl methacrylate/methacrylic acid/acrylic acid tetrapolymer and another acrylic interpolymer particularly in an aqueous or aqueous/alcoholic medium; hair spray, especially with pump action |
| 04/18/2006 | US7029659 aqueous solvent, organic cosolvent, and occlusive agent, especially petrolatum, to form an occlusive layer on the skin for the topical administration of pharmaceuticals |
| 04/18/2006 | US7029658 Delivery of antidepressants through an inhalation route |
| 04/18/2006 | CA2409059C Stabilized aqueous suspensions for parenteral use |
| 04/18/2006 | CA2346335C Sertraline oral concentrate |
| 04/18/2006 | CA2268825C Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| 04/18/2006 | CA2182282C Process for preparing fine particle pharmaceutical formulations |
| 04/18/2006 | CA2089446C Composition for stabilizing blood plasma during pasteurization and pasteurized plasmic solution, for therapeutic purposes |
| 04/13/2006 | WO2006039704A2 Pharmaceutical composition and method for treating a joint capsule arthropathy |
| 04/13/2006 | WO2006039667A2 Water-based delivery systems |
| 04/13/2006 | WO2006039659A1 Bioadhesive delivery system for transmucosal delivery of beneficial agents |
| 04/13/2006 | WO2006039418A2 Human monoclonal antibodies to fc gamma receptor ii (cd32) |
| 04/13/2006 | WO2006039369A1 Microparticles and nanoparticles containing a lipopolymer |
| 04/13/2006 | WO2006038931A2 Odor-reducing quinone compounds |
| 04/13/2006 | WO2006038661A1 Medicinal composition, process for producing the same, and method of stabilizing dihydropyridine compound in medicinal composition |
| 04/13/2006 | WO2006038552A1 Composition containing fine particles and process for producing the same |
| 04/13/2006 | WO2006038185A2 Use of the staudinger ligation in imaging and therapy end kits for imaging and therapy |
| 04/13/2006 | WO2006038184A2 Compounds, kits and methods for use in medical imaging |
| 04/13/2006 | WO2006038110A2 Amphiphilic star block copolymers |
| 04/13/2006 | WO2006037960A2 T-cell receptors containing a non-native disulfide interchain bond linked to therapeutic agents |
| 04/13/2006 | WO2006037827A1 Solid pharmaceutical composition comprising the thiazolyl methyl ester of [5s-(5r*,8r*,10r*,11r*)]-10-hydroxy-2-methyl-5-(1-methylethyl)-1-[2-1(1-methylethyl)-4-thiazolyl]-3,6-dioxo-8,11-bis(phenylmethyl)-2,4,7,12-tetraazatridecan-13-oic acid and preparation method thereof |
| 04/13/2006 | WO2006037738A1 Modifying surfaces of lactose serving as an auxiliary agent to be used for powder inhalants |
| 04/13/2006 | WO2006037736A1 Novel powder inhalation preparations based on modified lactose blends that are used as adjuvants |
| 04/13/2006 | WO2006037229A1 Formulation of multivalent antibody constructs and use of same for cancer therapy |
| 04/13/2006 | WO2006019327A3 Deuterium depleted water (ddw) using as adjuvant in cancer therapy for cytostatics toxicity reduction |
| 04/13/2006 | WO2006017347A3 Opthalmic compositions and methods for treating ophthalmic conditions |
| 04/13/2006 | WO2005117998A3 Smvt transporters expressed in cancer cells |
| 04/13/2006 | WO2005117952A3 Treatment methods utilizing albumin-binding proteins as targets |
| 04/13/2006 | WO2005116255A3 Aptamer-toxin molecules and method for using same |
| 04/13/2006 | WO2005112997A3 Composition and method for introduction of dna directed or direct rna interference sequence into targeted cells and tissues |
| 04/13/2006 | WO2005100405A3 Phosphorylcholine conjugates and corresponding antibodies |
| 04/13/2006 | WO2005099763A3 Composition for intracellular transfer of a nucleic acid |
| 04/13/2006 | WO2005097146A3 Dairy components effective for fat loss |
| 04/13/2006 | WO2005072479A3 Polymer-bound antibody concer therapeutic agent |
| 04/13/2006 | WO2005070465A3 Lipid-based dispersions useful for drug delivery |
| 04/13/2006 | WO2005067893A3 Pharmaceutical compositions comprising midazolam in a high concentration |
| 04/13/2006 | WO2005051429A3 Targeted conjugates with a modified saccharide linker |
| 04/13/2006 | US20060079516 Highly concentrated stable meloxicam solutions |
| 04/13/2006 | US20060079460 Purified LH |
| 04/13/2006 | US20060079459 Stabilized compositions comprising tissue factor pathway inhibitor protein or tissue factor pathway inhibitor variant proteins |
| 04/13/2006 | US20060079455 Peptide nanostructures encapsulating a foreign material and method of manufacturing same |
| 04/13/2006 | US20060079450 Polypeptide that does not include an N-linked glycosylation site such as interleukin-11 stabilized with hydroxyethyl starch and a disaccharide such as trehalose and sucrose; stable for at least 9 months when stored at 60 degrees C. |
| 04/13/2006 | US20060078969 Regulated transcription of targeted genes and other biological events |
| 04/13/2006 | US20060078626 Opthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative |
| 04/13/2006 | US20060078613 Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy |
| 04/13/2006 | US20060078607 Liposome formulation of 6,9-bis[(2-aminoethyl)-amino]benzo[g]isoquinoline-5, 10-dione dimaleate |
| 04/13/2006 | US20060078598 Animal feed containing an encapsulated ingredient |
| 04/13/2006 | US20060078597 Ascorbic acid salt suspensions and use thereof as antioxidants |
| 04/13/2006 | US20060078596 Treatment of muscle fatigue |
| 04/13/2006 | US20060078595 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 04/13/2006 | US20060078594 Iron complex |
| 04/13/2006 | US20060078593 Nutritional compostions comprising a soluble viscous fiber in a solid crisp matrix |
| 04/13/2006 | US20060078575 Low profile combination device for gastrostomy or jejunostomy applications having anti-granuloma formation characteristics |
| 04/13/2006 | US20060078547 Lactobacillus salivarius strain, AH102, AH103, AH105, AH109 or AH110 or mutants or variants are useful in the prophylaxis and/or treatment undesirable gastrointestinal inflammatory activity, such as inflammatory bowel disease or irritable bowel syndrome |
| 04/13/2006 | US20060078542 Gel-based delivery of recombinant adeno-associated virus vectors |
| 04/13/2006 | US20060078504 Sustanined-release pharmaceutical composition for lung administration |
| 04/13/2006 | US20060078496 Method of drug delivery to interstitial regions of the myocardium |
| 04/13/2006 | DE10252032B4 Verfahren zur Herstellung von sphärischen Partikeln und sphärische Partikel A process for the production of spherical particles and spherical particles |
| 04/13/2006 | DE102004046172A1 Offenporiger Polyurethanschaum ohne Hautbildung, Formulierung zu seiner Herstellung und Verwendung desselben Of the same open-cell polyurethane foam without skin formation, formulation for its preparation and use |
| 04/13/2006 | DE10040897B4 Nanoskalige poröse Fasern aus polymeren Materialien Nanoscale porous fibers from polymeric materials |
| 04/13/2006 | CA2582949A1 Liposomes with improved drug retention for treatment of cancer |
| 04/13/2006 | CA2582937A1 Formulation of multivalent antibody constructs and use of same for cancer therapy |
| 04/13/2006 | CA2582668A1 Nanoparticles comprising antigens and adjuvants, and immunogenic structures |
| 04/13/2006 | CA2581282A1 Solid pharmaceutical preparation |